Document is current
Any future updates will be listed below
-
Authors
Toragall, Veeresh
Rester, Ann C.
Begum, Salma
Shofolawe-Bakare, Oluwaseyi T.
Hulugalla, Kenneth
Monroe, Jerry D.
Bentley, John P.
Gibert, Yann
Werfel, Thomas A.
-
Funding
Funding for this research was provided by:
American Cancer Society (RSG-21-114-01-MM)
American Cancer Society (RSG-21-114-01-MM)
American Cancer Society (RSG-21-114-01-MM)
American Cancer Society (RSG-21-114-01-MM)
NIH (P20GM104357)
NIH (P20GM121334)
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 26 October 2025
First Online: 13 November 2025
Declarations
:
: All procedures were performed in compliance with the Institutional Animal Care and Use Committee (IACUC, protocol number: 23 − 007)–approved protocol of the University of Mississippi and following National Institutes of Health (NIH) guidelines.
: Cumberland Pharmaceuticals provided ifetroban for the studies as part of a research agreement between Cumberland and the University of Mississippi.
